The stock of UnitedHealth Group (UNH -1.09%) is trading around its five-year lows. It plummeted after posting poor earnings numbers earlier this year amid rising costs.
The market is overestimating the negative impact of policy crackdowns, DoJ investigations, and Medicare/Medicaid cuts on UnitedHealth Group's long-term fundamentals. While legislative and regulatory headwinds will likely compress margins and slow growth, UNH's diversified business model and strong market position provide resilience and upside potential. Optum Insights is a key growth catalyst, ...
Despite a rare earnings miss, CEO departure, DOJ investigation, and guidance withdrawal, we view UNH as a strong long-term buy at current depressed valuations. UNH's robust balance sheet, healthy dividend coverage, and potential for substantial share buybacks should create a valuation floor and support near-term downside protection. Even in a worst-case 30% y/y EPS decline, UNH trades well belo...
As we put the finishing touches on a first half that was littered with uncertainty, a small treasure is seen in global dividend trends. Thirty percent of the companies Wall Street Horizon tracks announced shareholder-payout increases in the second quarter—the best Q2 mark going back to 2021.
Global uncertainty is everywhere, but I stick to what works: top-tier dividend stocks with secular growth, great balance sheets, and attractive value. I present two high-quality, undervalued dividend stocks. Both have unique growth stories and the potential to deliver major long-term outperformance. I don't know where the markets are headed, but I believe these stocks are positioned to grow wea...
Although UnitedHealth's (NYSE: UNH) stock has plummeted 40% in 2025, insider confidence in the company has surged to new highs, with executive purchases of shares spiking by nearly 3,000%.
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.